Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Non Small Cell Lung Cancer Medullary Thyroid Cancer Colon Cancer Breast Cancer Pancreatic Cancer Papillary Thyroid Cancer Other Solid Tumors With Evidence of Activating RET Alteration Thyroid Neoplasms Thyroid Cancer, Papillary Thyroid Diseases Selpercatinib
Lead Scientists at University of California Health
- Mykola Onyshchenko (ucla)
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 17 research publications
- Lyudmila Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- Alain Algazi (ucsf)
Associate Professor, Medicine, School of Medicine. Authored (or co-authored) 68 research publications
- not accepting new patients
- Start Date
- Loxo Oncology, Inc.
- Study Type
- Expanded Access
- Last Updated